Tissue Changes Following Thoracic Myofascial Release

NCT06651671 | Completed

• 1 other identifier: Rowan-PRO-2022-348
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

Brief Summary: The goal of this clinical trial is to determine the efficacy of myofascial release in altering the parameters of muscle tone, stiffness, and viscoelasticity in young adults. The main questions it aims to answer are: What is the efficacy of myofascial release in altering muscle tone, stiffness, and viscoelasticity? What is the efficacy of light hands-on sham as a control? Are there differences in these parameters between men and women? What is the reliability of MyotonPro use in young adults? Researchers will randomly allocate and compare the treatment group, which receives osteopathic manipulative medicine (OMM) in the form of 30 seconds of indirect myofascial release followed by 30 seconds of direct myofascial release, to the control group, which receives 1 minute of light hands-on traps placebo, to see if there are differences in muscle tone, stiffness, and viscoelasticity.

Conditions

Myofascial Dysfunction; Myofascial Release

Keywords

Myofascial Release; Osteopathic Manipulative Medicine

Outcome Measures

Primary Outcomes (3)

• Tissue Biomechanical Parameters

  Myofascial Tone assessed using a Myotonometer

  Baseline will be assessed Immediately pre-treatment, with follow up assessed immediately after the intervention

• Tissue Biomechanical Parameters

  Myofascial Stiffness assessed using a Myotonometer

  Baseline will be assessed Immediately pre-treatment, with follow up assessed immediately after the intervention

• Tissue Biomechanical Parameters

  Myofascial Elasticity assessed using a Myotonometer

  Baseline will be assessed Immediately pre-treatment, with follow up assessed immediately after the intervention

Study Arms (2)

Treatment; MFR

EXPERIMENTAL

The treatment group received 30 seconds of direct and indirect myofascial release performed by the same practicing osteopathic physician.

Procedure: Myofascial release

Control

SHAM COMPARATOR

The sham control group received one minute of light sham touch performed by a medical student.

Procedure: Sham (No Treatment)

Interventions

Myofascial release PROCEDURE

THe treatment group was instructed to lay prone on the treatment table such that the skin on their upper back was visible. Participants then received direct and indirect myofascial release for 30 seconds each, performed by the same osteopathic physician.

Treatment; MFR

Sham (No Treatment) PROCEDURE

The medical student gently placed their hands on the patients back for 60 seconds without manipulating the tissue in any way.

Control

Eligibility Criteria

• Age: 18 Years - 35 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• year old healthy participants

You may not qualify if:

• BMI \>30
• No current thoracic spine injuries such as compression fractures or spinal fusions

Sponsors & Collaborators

• Rowan University: lead

Study Sites (1)

Rowan University, Neuromuscular Institute

Stratford, New Jersey, 08043, United States

Location

MeSH Terms

Interventions

Myofascial Release Therapy; salicylhydroxamic acid

Intervention Hierarchy (Ancestors)

Massage; Therapy, Soft Tissue; Musculoskeletal Manipulations; Complementary Therapies; Therapeutics; Physical Therapy Modalities; Rehabilitation

Study Officials

• Alexander King, DO

  Rowan-Virtua School of osteopathic medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Program Director, Assistant Professor

Study Record Dates

• First Submitted: September 27, 2024
• First Posted: October 22, 2024
• Study Start: March 30, 2023
• Primary Completion: July 30, 2023
• Study Completion: July 31, 2023
• Last Updated: October 22, 2024

Record last verified: 2024-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)